ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Liposome-coated CaO2 nanoblockers for enhanced checkpoint blockade therapy by inhibiting PD-L1 de novo biosynthesis

Che, Ruijun; Han, Dandan; Wang, Fei; Liu, Huifang; Fan, Miao; Yan, Hongyu; Xiao, Tingshan; Wang, Zhaoshuo; Zhou, Xiaohan; Wang, Xueyi; Zhang, Kaihan; Ou, Caiwen; Zhang, Jinchao*; Li, Zhenhua*南方医科大学
Nano Research2023-5DOI: 10.1007/s12274-022-5362-7
1被引6阅读
引用收藏
分享

摘要

The blocking of the immune checkpoint pathway with antibodies, especially targeting to programmed death-1/programmed death ligand-1 (PD-1/PD-L1) pathway, was currently a widely used treatment strategy in clinical practice. However, the shortcomings of PD -L1 antibodies were constantly exposed with the deepening of its research and their therapeutic effect was limited by the translocation and redistribution of intracellular PD -L1. Herein, we proposed to improve immune checkpoint blockade therapy by using liposomes-coated CaO2 (CaO2@Lipo) nanoparticles to inhibit the de novo biosynthesis of PD -L1. CaO2@Lipo would produce oxygen and reduce hypoxia-inducible factor-1a (HIF-1a) level, which then downregulated the expression of PD-L1. Our in vitro and in vivo results have confirmed CaO2@Lipo promoted the degradation of HIF-la and then downregulated the expression of PD -L1 in cancer cells for avoiding immune escape. Furthermore, to mimicking the clinical protocol of anti -PD -L1 antibodies + chemo-drugs, CaO2@Lipo was combined with doxorubicin (DOX) to investigate the tumor inhibition efficiency. We found CaO2@Lipo enhanced DOX-induced immunogenic cell death (ICD) effect, which then promoted the infiltration of T cells, strengthened the blocking effect, and thus provided an effective means to overcome the traditional immune checkpoint blockade treatment.

学科与关键词

关键词
immune checkpoint blockade therapyoxygen -producinghypoxia-inducible-1a) programmed death ligand1 1(PD-L1) redistributionimmunogenic cell death
相关
加载中…
  • Designing Peptide-Based Nanoinhibitors of Programmed Cell Death Ligand 1 (PD-L1) for Enhanced Chemo-immunotherapy
    Xie, Fengjuan; Tang, Shasha; Zhang, Ye; Zhao, Yinbing; Lin, Yingying; Yao, Yining; Wang, Meiyan*; Gu, Zhengying*; Wan, Jingjing*ACS Nano, 2024, 18(2): 1690-1701.
  • Combining PD-L1 inhibitors with immunogenic cell death triggered by chemo-photothermal therapy via a thermosensitive liposome system to stimulate tumor-specific immunological response
    Yu, Jie; He, Xidong; Wang, Zigui; Wang, Yupeng; Liu, Sha; Li, Xiaoyuan*; Huang, Yubin*Nanoscale, 2021, 13(30): 12966-12978.被引 32
  • Nanobubbles containing PD-L1 Ab and miR-424 mediated PD-L1 blockade, and its expression inhibition to enable and potentiate hepatocellular carcinoma immunotherapy in mice
    Liu, Yun; Xie, Qian; Ma, Yao; Lin, Chen; Li, Jinlin; Hu, Bing; Liu, Chaoqi*; Zhao, Yun*International Journal of Pharmaceutics, 2022, 629: 122352.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Nano Research
发表日期
2023-05
卷期
第 16 卷, 第 5 期
页码
7227-7236
DOI
10.1007/s12274-022-5362-7
语言
ENGLISH
期刊收录
CAST-L
成果收录
SCIE
资助标注
National Natural Science Foundation of China [31971304, 32271420, 21977024]; Beijing-Tianjin-Hebei Basic Research Cooperation Project [19JCZDJC64100]; Cross-disciplinary Project of Hebei University [DXK201916]; One Hundred Talent Project of Hebei Province [E2018100002]; Science Fund for Creative Research Groups of Nature Science Foundation of Hebei Province [B2021201038]; Guangdong Basic and Applied Basic Research Foundation [2021B1515120065]

作者

  • C

    Che, Ruijun (第一作者)

    hebei univ

  • H

    Han, Dandan

    hebei univ

查看全部 14 位作者收起作者
  • W

    Wang, Fei

    southern med univ

  • L

    Liu, Huifang

    hebei univ

  • F

    Fan, Miao

    hebei univ

  • Y

    Yan, Hongyu

    hebei univ

  • X

    Xiao, Tingshan

    hebei univ

  • W

    Wang, Zhaoshuo

    hebei univ

  • Z

    Zhou, Xiaohan

    southern med univ

  • W

    Wang, Xueyi

    southern med univ

  • Z

    Zhang, Kaihan

  • O

    Ou, Caiwen

    southern med univ

  • Z

    Zhang, Jinchao (通讯)

    hebei univ

  • L

    Li, Zhenhua (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417